Introduction {#section1-1178631019839010}
============

CHARGE syndrome (MIM 214800) is a multifaceted condition affecting between 1 in 8500 and 1 in 17 000 individuals.^[@bibr1-1178631019839010]^ The acronym CHARGE was established based on the combination of patients' phenotypes, such as coloboma, heart defect, atresia choanae (also known as choanal atresia), retardation of growth and/or development, genital defects, ear anomalies, and/or deafness in patients. All malformations related to CHARGE syndrome occur early in the first trimester of pregnancy, while growth and developmental retardation become more obvious as the child matures. In some patients, clinical phenotype overlaps with those described for other syndromes, such as DiGeorge syndrome, velocardiofacial, oculo-auriculo-vertebral, and Kallmann syndromes.^[@bibr2-1178631019839010],[@bibr3-1178631019839010]^ Clinical diagnosis is made with a set of criteria ([Table 1](#table1-1178631019839010){ref-type="table"}) and CHARGE patients typically have all 4 major or 3 major and 3 minor features, while individuals suspected to have CHARGE syndrome may only have 1 or 2 major and several minor characteristics. Subsequent molecular confirmation enables genetic counselling concerning recurrence risk.

###### 

Major and minor diagnostic characteristics of CHARGE syndrome and phenotype of the proband.^[@bibr3-1178631019839010]^

![](10.1177_1178631019839010-table1)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                                                                 Manifestations                                                                                                                                                                                                           Frequency     Proband
  ------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------- ----------------------------------------------------------------------------------------
  *Major diagnostic characteristics*                                                                                                                                                                                                                                                                                     

  Ocular coloboma                                                                 Coloboma of the iris, retina, choroid, disc; microphthalmia                                                                                                                                                              80%--90%      • Bilateral choroid coloboma involving optic nerve

  Choanal atresia or stenosis                                                     Unilateral/bilateral: bony or membranous atresia/stenosis                                                                                                                                                                50%--60%      

  Cranial nerve dysfunction or anomaly                                            I: hyposmia or anosmia                                                                                                                                                                                                   Frequent      

                                                                                  VII: facial palsy (unilateral or bilateral)                                                                                                                                                                              \>40%         

                                                                                  VIII: hypoplasia of auditory nerve                                                                                                                                                                                       Frequent      

                                                                                  IX/X: swallowing problems with aspiration                                                                                                                                                                                70%--90%      • Swallowing problems

  Ear                                                                             Outer ear: short, wide ear with little or no lobe, 'snipped off' helix, prominent antihelix that is often discontinuous with tragus, triangular concha, decreased cartilage; often protruding and usually asymmetric;\   80%--100%     • Smaller and wide right ear\
                                                                                  Middle ear: ossicular malformations;\                                                                                                                                                                                                  • Bilateral sensorineural hearing loss
                                                                                  Mondini defect of the cochlea;\                                                                                                                                                                                                        
                                                                                  Temporal bone abnormalities; absent or hypoplastic semicircular canals                                                                                                                                                                 

  *Minor diagnostic characteristics*                                                                                                                                                                                                                                                                                     

  Genital hypoplasia                                                              Males: micropenis, cryptorchidism\                                                                                                                                                                                       50%--60%      • Micropenis, cryptorchidism
                                                                                  Females: hypoplastic labia                                                                                                                                                                                                             

  Males and females: delayed puberty secondary to hypogonadotropic hypogonadism   Frequent                                                                                                                                                                                                                               

  Developmental delay                                                             Delayed milestones, hypotonia                                                                                                                                                                                            Almost 100%   • Delayed psychomotor development\
                                                                                                                                                                                                                                                                                                                         • Autism spectrum disorder

  Cardiovascular malformation                                                     Including conotruncal defects (eg, tetralogy of Fallot), AV canal defects, and aortic arch anomalies                                                                                                                     75%--85%      • Small atrial septal defect

  Growth deficiency                                                               Short stature, usually postnatal with or without growth hormone deficiency                                                                                                                                               70%--80%      • Weight and height \<3rd centile

  Orofacial cleft                                                                 Cleft lip and/or palate                                                                                                                                                                                                  15%--20%      

  Tracheoesophageal (TE) fistula                                                  TE defects of all types                                                                                                                                                                                                  15%--20%      

  Distinctive facial features                                                     Square face with broad prominent forehead, prominent nasal bridge and columella, flat midface                                                                                                                            70%--80%      • Prominent forehead, prominent metopic ridge

  Other features                                                                                                                                                                                                                                                                                                         • Congenital umbilical hernia and congenital hernia at the linea alba;\
                                                                                                                                                                                                                                                                                                                         • Mildly hypoplastic inferior vermis and slight dilatation of the lateral ventricles;\
                                                                                                                                                                                                                                                                                                                         • Hypoglycemic episodes
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviation: AV, atreoventricular.

Methods {#section2-1178631019839010}
=======

Whole exome sequencing {#section3-1178631019839010}
----------------------

DNA was extracted from peripheral blood lymphocytes using the phenol-chloroform extraction method. The proband and his healthy parents were assessed by whole exome sequencing (WES). We followed the procedure we routinely and successfully used to identify the cause of Mendelian diseases.^[@bibr4-1178631019839010][@bibr5-1178631019839010][@bibr6-1178631019839010][@bibr7-1178631019839010]--[@bibr8-1178631019839010]^ Briefly, exomes were captured using the Agilent SureSelect Human All Exon V5 enrichment kit and multiplex sequenced (6-plex) on an Illumina HiSeq 2500 platform to reach about 100-fold coverage on average and were mapped according to the human reference genome build 38. Variants were filtered based on allele frequency in ExAC and in the Lithuanian population, pathogenicity predictions scores (SIFT, PolyPhen, MutationTaster, CADD),^[@bibr9-1178631019839010][@bibr10-1178631019839010][@bibr11-1178631019839010][@bibr12-1178631019839010]--[@bibr13-1178631019839010]^ and inheritance patterns including autosomal-recessive, X-linked, and *de novo*/autosomal dominant using the Varapp filtering software.^[@bibr14-1178631019839010]^ Sanger sequencing confirmed the anticipated segregation of the potentially causative variant.

Results {#section4-1178631019839010}
=======

The proband (3 years 7 months old; [Figure 1A](#fig1-1178631019839010){ref-type="fig"} and [B](#fig1-1178631019839010){ref-type="fig"}) is the firstborn male child of healthy non-consanguineous parents. Family history was unremarkable, with no undue exposure to teratogens reported. The pregnancy was complicated by imminent preterm labour at 32 weeks of gestation. The patient was born at 34 weeks of gestation with the umbilical cord wrapped around his neck and green amniotic fluid. The propositus head circumference, weight, and length at birth were 34 cm (90th centile), 2275 g (50th centile), and 49 cm (90th centile), respectively. On delivery, his Apgar scores at 1 minute and 5 minutes were 8 and 8, respectively. He was apneic at birth and was intubated for several days. He also received nasogastric tube feeding to circumvent swallowing issues. A brain magnetic resonance imaging (*MRI*) examination performed at 1.5 months of age showed mildly hypoplastic inferior vermis, slight dilatation of the lateral ventricles, and dilated fourth ventricle ([Figure 1C](#fig1-1178631019839010){ref-type="fig"} and [D](#fig1-1178631019839010){ref-type="fig"}). Brain MRI examination has not revealed anomalies of olfactory bulb, optic nerves, or pituitary gland. At 4 months of age, a gastrostomy tube was placed. Multiple congenital birth defects were observed soon after birth. An echocardiogram identified a small atrial septal defect, while a brain ultrasonographic assessment revealed inferior *vermian hypoplasia*. Bilateral choroid coloboma involving the optic nerves was diagnosed by an ophthalmologist at 13 months. Surgical correction was performed for a congenital umbilical hernia and a congenital hernia at the *linea alba*. Bilateral sensorineural hearing loss was managed with hearing aids. Hypoglycemic episodes started to manifest at approximately 9 months of age, and therapy with slow release cornstarch was initiated. Notably, there has also been clear psychomotor delay as the proband could sit without support by 15 months of age and walk independently at 37 months of age. His first teeth erupted at 14 months of age. The boy has no expressive language. At 2 years 8 months old, his psychomotor development was evaluated to be in the range of 3 (self-help) *to 10* (fine motor) months according the Diagnostic Inventory for Screening Children (DISC) scale. In addition, he was diagnosed with autism spectrum disorder at 2 years 9 months of age. During his last examination, at the age of 3 years 7 months, his weight was 11.5 kg (\<3rd centile) and his height was 88 cm (\<3rd centile). He had a prominent metopic ridge, smaller and wide right ear, sacral dimple, clinodactyly of the 5th fingers, micropenis, and cryptorchidism. He was still suffering from laryngomalacia and severe feeding problems necessitating gastrostomy tube feeding. Frequent feeds and uncooked cornstarch every 6 hours was used to prevent hypoglycemic episodes. In summary, the proband presents with 3 major and 5 minor features of CHARGE syndrome ([Table 1](#table1-1178631019839010){ref-type="table"}) combined with additional features.

![(A) Front and (B) side views of the patient at 1 year and 9 months of age. Brain MRI at 1.5 months of age showed (C) slight dilatation of the lateral ventricles, mildly hypoplastic inferior vermis and (D) dilated fourth ventricle. (E) An electropherogram of the genomic DNA sequence of the patient showed a *de novo* duplication in *CHD7*: c.6341_6358dup (Asp2119_Pro2120ins6) A mutated sequence with duplication in red written beneath. (F) Alignment of CHD7 protein fragment for 9 different placental mammal species confirmed that the Asp2119_Pro2120ins6 non-frameshift insertion affects an evolutionary conserved region. Secondary structures of the peptide encoded by the wild type (left) and Asp2119_Pro2120ins6 mutated (right) exon 31 of CHD7 are shown as rainbow ribbons. (G) The new short alpha helix that is formed by the inserted amino acid residues is in yellow. Models of wild-type and mutated protein structure were formed using SWISS-MODEL software.^[@bibr15-1178631019839010]^ MRI indicates magnetic resonance imaging.](10.1177_1178631019839010-fig1){#fig1-1178631019839010}

As no cytogenetic alterations were identified, we assessed the genome of the proband and his parents by WES. We identified a *de novo* 18 nucleotides duplication in exon 31 of the *CHD7* gene (c.6341_6358dup, p.Asp2119_Pro2120ins6); NM_017780; NP_060250; MIM 214800) confirmed by Sanger sequencing ([Figure 1E](#fig1-1178631019839010){ref-type="fig"}), which affects an evolutionary constrained region ([Figure 1F](#fig1-1178631019839010){ref-type="fig"}). Modelization of the putatively encoded mutated protein suggests that the insertion of this chain of 6 amino acid residues potentially substitutes a linear chain into a short alpha helix ([Figure 1G](#fig1-1178631019839010){ref-type="fig"}). The other deleterious *de novo* variants, which contribute to the current patient phenotype, were not identified. All unique *de novo* variants identified for this proband are listed in [Table 2](#table2-1178631019839010){ref-type="table"}.

###### 

List of *de novo* variants identified for the proband.

![](10.1177_1178631019839010-table2)

  Chromosome   Start       Reference allele     Alternative allele                Gene symbol    Aa change       Impact                     Genotype
  ------------ ----------- -------------------- --------------------------------- -------------- --------------- -------------------------- --------------
  **chr20**    52557934    GGT                  G                                 *AC005220.3*                   Splice donor variant       Heterozygous
  **chr7**     150811966   G                    A                                 *AGAP3*        G/S             Missense variant           Heterozygous
  **chr7**     150811967   G                    A                                 *AGAP3*        G/D             Missense variant           Heterozygous
  **chr11**    13435092    T                    G                                 *BTBD10*       K/Q             Missense variant           Heterozygous
  **chr11**    66512290    G                    GGGCGGCGGCGGC                     *C11orf80*     G/GAAAA         Inframe insertion          Heterozygous
  **chr2**     153476066   G                    GCCACCCCCCCCCCCA                  *FMNL2*        −/PPPPP         Inframe insertion          Heterozygous
  **chr6**     30996720    C                    CAGGCTCTGAGACCACCACAGCCTCTACTGA   *MUC22*        T/TGSETTTASTE   Inframe insertion          Heterozygous
  **chr19**    2015540     GGGCGGCGGCGGC        G                                 *BTBD2*        AAAA/−          Inframe deletion           Homozygous
  **chr3**     42251577    C                    CGGA                              *TRAK1*        T/TE            Inframe insertion          Heterozygous
  **chr14**    73874252    G                    --                                *PTGR2*                        NA                         Heterozygous
  **chr4**     87615711    AATAGTAGTGACAGCAGC   --                                *DSPP*                         Non-frameshift deletion    Heterozygous
  **chr8**     60853065    --                   ATCACATCCTCAATGACC                *CHD7*         −/HILNDH        Non-frameshift insertion   Heterozygous

*De novo* variant in *CHD7* gene associated with CHARGE syndrome is marked in grey.

Discussion {#section5-1178631019839010}
==========

Alterations in *CHD7* have been identified in more than two-third of all children, who fulfil the clinical diagnostic criteria for CHARGE syndrome.^[@bibr16-1178631019839010][@bibr17-1178631019839010]--[@bibr18-1178631019839010]^ Truncating variants including nonsense, frameshift, and splice variants (89%) that typically result in haploinsufficiency are the most frequently encountered followed by missense (8%) variants.^[@bibr17-1178631019839010],[@bibr19-1178631019839010],[@bibr20-1178631019839010]^ *CHD7* encodes a chromodomain helicase DNA-binding protein, which plays a significant role in early embryonic development and controls gene expression via chromatin remodelling during the cell cycle.^[@bibr21-1178631019839010]^

Besides the duplication described here, other variants affecting the same region in the protein have been identified, for example, the *de novo* missense variant c.6347T\>A; p.Ile2116Asn (CM090041) that changes a hydrophobic into a polar amino acid. The associated patient presented with a milder pheno-type than our proband characterized by cleft palate, auricular dysplasia, nystagmus, bilateral perceptive deafness, and semi-circular canal hypoplasia.^[@bibr22-1178631019839010]^ Similarly, the c.6322G\>A; p.Gly2108Arg (CM080142) missense variant has been detected in 3 patients with mild CHARGE syndrome features, which include unilateral optic nerve coloboma and microphthalmia, bilateral sensorineural deafness, dysmorphic ears, hypoplastic semicircular canals, and bifid uvula.^[@bibr23-1178631019839010]^ The association between the insertion of the HILNDH peptide and a severe phenotype is not surprising as it is predicted to form a novel alpha helix within a highly conserved region of the protein.

While additional work is necessary to understand this complex disease, this study further expands the understanding of CHARGE syndrome pathogenesis and suggests that severe CHARGE syndrome phenotypes can be caused by deletions, point mutations,^[@bibr17-1178631019839010]^ and duplications/insertions.
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